Free Trial
LON:GNS

Genus (GNS) Share Price, News & Analysis

Genus logo
GBX 2,420 +35.00 (+1.47%)
As of 11:49 AM Eastern

About Genus Stock (LON:GNS)

Key Stats

Today's Range
2,375
2,445
50-Day Range
1,924
2,420
52-Week Range
1,424
2,485
Volume
293,813 shs
Average Volume
240,197 shs
Market Capitalization
£1.58 billion
P/E Ratio
200.60
Dividend Yield
1.32%
Price Target
GBX 2,650
Consensus Rating
Buy

Company Overview

Genus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

GNS MarketRank™: 

Genus scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Genus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Genus has only been the subject of 2 research reports in the past 90 days.

  • Read more about Genus' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genus is 200.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.50.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genus is 200.60, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.10.

  • Price to Earnings Growth Ratio

    Genus has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Genus has a P/B Ratio of 2.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for GNS.
  • Dividend Yield

    Genus pays a meaningful dividend of 1.69%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Genus does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Genus is 265.25%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Genus' dividend.
  • Short Interest

    There is no current short interest data available for GNS.
  • News Sentiment

    Genus has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Genus this week, compared to 1 article on an average week.
  • Search Interest

    18 people have searched for GNS on MarketBeat in the last 30 days. This is an increase of 260% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Genus insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.75% of the stock of Genus is held by insiders.

  • Percentage Held by Institutions

    77.79% of the stock of Genus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Genus' insider trading history.
Receive GNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

GNS Stock News Headlines

Genus Stock Price History
5 Stocks That Could Double Your Investment in 2025
5 Stocks That Could Double in 2025 🚀 Our analysts have identified five stocks with the potential to double in 2025. From a company poised to lead the crypto ETF market to an innovator in fuel cell technology for AI and data centers, these picks could be game-changers for your portfolio.
Kepler Capital Keeps Their Buy Rating on Genus plc (GNS)
See More Headlines

GNS Stock Analysis - Frequently Asked Questions

Genus' stock was trading at GBX 1,550 at the start of the year. Since then, GNS stock has increased by 56.1% and is now trading at GBX 2,420.

Genus plc (LON:GNS) issued its quarterly earnings data on Thursday, February, 27th. The company reported $39.80 earnings per share for the quarter. Genus had a net margin of 1.18% and a trailing twelve-month return on equity of 1.41%.
Read the conference call transcript
.

Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genus investors own include Meta Platforms (META), Lloyds Banking Group (LLOY), Rolls-Royce Holdings plc (RR.L), AstraZeneca (AZN), Barclays (BARC), BP (BP) and Clinigen Group (CLIN).

Company Calendar

Last Earnings
2/27/2025
Today
7/17/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Personal Services
Current Symbol
LON:GNS
CIK
N/A
Fax
N/A
Employees
480
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 2,750
Low Price Target
GBX 2,550
Potential Upside/Downside
+9.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 12.06
Trailing P/E Ratio
200.60
Forward P/E Ratio
34.10
P/E Growth
2.87
Net Income
£7.87 million
Net Margins
1.18%
Pretax Margin
N/A
Return on Equity
1.41%
Return on Assets
3.31%

Debt

Debt-to-Equity Ratio
53.12
Current Ratio
1.80
Quick Ratio
1.08

Sales & Book Value

Annual Sales
£666.67 million
Price / Sales
2.38
Cash Flow
GBX 47.86 per share
Price / Cash Flow
50.56
Book Value
GBX 827.95 per share
Price / Book
2.92

Miscellaneous

Outstanding Shares
65,483,478
Free Float
N/A
Market Cap
£1.58 billion
Optionable
Not Optionable
Beta
0.37
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (LON:GNS) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners